Literature DB >> 32731179

Ginsenoside Rg1 prevent and treat inflammatory diseases: A review.

Yan Gao1, Juntong Li2, Jin Wang3, Xiang Li3, Jianping Li4, Shifeng Chu4, Lin Li3, Naihong Chen5, Lan Zhang6.   

Abstract

Ginseng has been used as reinforcing drugs or for traditional Chinese medicine in aging, inflammation, stress, diabetes mellitus, hepatic diseases and cancer. The aim of this current review is to provide an integrative overview of the uses, relative human diseases and related mechanisms of ginseng. Nowadays, numerous animal experiments and clinical studies conducted to investigate the efficacy and safety of ginseng components. Inflammation is an immune response that protects human from pathogens, toxins and other dangers, which is initiated by recognizing pathogen- or danger- associated molecular patterns. Inflammasomes are cytosolic protein complexes which form in response to challenges, which also controls the activity of caspase-1, important for maturation and release of cytokines. Ice protease-activating factor, oligomerization domain-like receptor family pyrin domain-containing 1 and absent in melanoma 2 inflammasome recognize peculiar substances, while NLRP3 inflammasome responds towards structurally and chemically diverse triggers. The functional relationship between ginsenosides and inflammasome provides new insight into the understanding of molecular mechanisms of ginsenoside-mediated anti-inflammatory actions. It also has applications regarding the development of anti-inflammatory remedies by ginsenoside-mediated targeting inflammasomes, which could prevent and treat inflammatory diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ginseng; Ginsenoside; Inflammatory diseases; NLRP3/Nrf2

Mesh:

Substances:

Year:  2020        PMID: 32731179     DOI: 10.1016/j.intimp.2020.106805

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  12 in total

1.  Protective Effect of Ginsenosides Rg1 on Ischemic Injury of Cardiomyocytes After Acute Myocardial Infarction.

Authors:  Chuang Yang; Guopan Jiang; Yue Xing
Journal:  Cardiovasc Toxicol       Date:  2022-09-20       Impact factor: 2.755

Review 2.  The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis.

Authors:  Tristan St-Laurent; Riadh Hammami
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 3.  Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease.

Authors:  Qin Li; Limor Rubin; Marta Silva; Shuai Li; Chao Yang; Philip Lazarovici; Wenhua Zheng
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

4.  Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/NLRP3 Inflammasome Pathway.

Authors:  Jian Kang; Yanhong Zhou; Chunyang Zhu; Tian Ren; Yong Zhang; Longfei Xiao; Binghu Fang
Journal:  Toxics       Date:  2022-05-27

5.  Ginsenoside Rg-1 prevents elevated cytosolic Ca2+ via store-operated Ca2+ entry in high-glucose-stimulated vascular endothelial and smooth muscle cells.

Authors:  A Young Han; Su Min Ha; You Kyoung Shin; Geun Hee Seol
Journal:  BMC Complement Med Ther       Date:  2022-06-22

6.  Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism.

Authors:  Hao Cheng; Juan Liu; Dandan Zhang; Jing Wang; Yuzhu Tan; Wuwen Feng; Cheng Peng
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

Review 7.  Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Authors:  Wei Jiang; Mingze Tang; Limin Yang; Xu Zhao; Jun Gao; Yue Jiao; Tao Li; Cai Tie; Tianle Gao; Yanxing Han; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

Review 8.  Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples.

Authors:  Boxun Zhang; Ke Liu; Haoyu Yang; Zishan Jin; Qiyou Ding; Linhua Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 5.293

Review 9.  Gut microbiota: A new target for T2DM prevention and treatment.

Authors:  Lulu Liu; Jiheng Zhang; Yi Cheng; Meng Zhu; Zhifeng Xiao; Guangcong Ruan; Yanling Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

Review 10.  Exploratory Systematic Review and Meta-Analysis of Panax Genus Plant Ingestion Evaluation in Exercise Endurance.

Authors:  Shingo Ikeuchi; Mika Minamida; Touma Nakamura; Masatoshi Konishi; Hiroharu Kamioka
Journal:  Nutrients       Date:  2022-03-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.